Drawing on deep therapy area expertise and forecasting data, Clarivate analysts have selected 15 Drugs to Watch in 2023 – key therapeutics nearing approval that, if green-lighted, are likely to be clinical and/or commercial game-changers. These therapeutics hold the potential to reshape the competitive landscape in their categories and deliver better outcomes to patients. This report can help pharmas and biotechs understand:

• What the near-term pipeline of innovative treatments looks like and how these treatments could answer unmet patient needs

• Where investment is flowing in the life sciences and what technologies and modalities companies are placing bets on

• Who some of the emerging biotechs building out these platforms are and what companies they’re partnering with as they seek to take their innovations to market.